Microneedle-mediated delivery of an nir-triggered nanoagent for synergistic anti-biofilm infection therapy
European Cells & Materials · 27.02.2026 · 55
DOI: 10.22203/ecm.v055a05 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Cells & Materials, online erschienen am 27.02.2026. Verfasst von F.F. Chen und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Post-surgical biofilm infections present a major clinical challenge due to their exceptional tolerance to antibiotics and the physical barrier of extracellular polymeric substance (EPS), calling for innovative non-antibiotic therapeutic strategies.
Methods
We engineered a synergistic platform by constructing curcumin-loaded iron-based metal-organic framework (MIL@Cur) nanoparticles and incorporating them into a dissolvable hyaluronic acid-based hydrogel to fabricate composite microneedles (MIL@Cur microneedle (FCMN)). The system was characterized for its physicochemical properties and evaluated for antibacterial efficacy in vitro and in a murine methicillin-resistant staphylococcus aureus (MRSA)-infected wound model.
Results
The MIL@Cur nanoparticles demonstrated well-defined morphology, high photothermal conversion efficiency (reaching >50°C under laser irradiation), and pH-responsive drug release. In vitro, MIL@Cur with laser irradiation achieved synergistic bacterial eradication through photothermal therapy and ironoverload-induced chemodynamic therapy (CDT), while also disrupting pre-formed biofilms and inhibiting new biofilm formation via quorum sensing (QS) suppression. The FCMN patch exhibited excellent mechanical strength and efficient transdermal delivery. In vivo, the FCMN + Laser group showed accelerated wound closure, ∼ 2-log reduction in bacterial load, enhanced collagen deposition and angiogenesis, and no systemic toxicity.
Conclusions
This microneedle-mediated platform effectively combines multiple antimicrobial modalities, providing a powerful and translatable strategy for treating stubborn biofilm infections and promoting wound repair.
Zitieren
APA
Chen, F., Zhang, L., Wang, L., Zhu, H., Ma, K., Yang, N., Meng, X., Pang, Z., & Xu, D. (2026). Microneedle-mediated delivery of an nir-triggered nanoagent for synergistic anti-biofilm infection therapy. European Cells & Materials, 55. https://doi.org/10.22203/ecm.v055a05
Vancouver
Chen F, Zhang L, Wang L, Zhu H, Ma K, Yang N, et al. Microneedle-mediated delivery of an nir-triggered nanoagent for synergistic anti-biofilm infection therapy. European Cells & Materials. 2026;55. doi:10.22203/ecm.v055a05
BibTeX
@article{Chen2026,
author = {Chen, F.F. and Zhang, L.S. and Wang, L.Y. and Zhu, H.Y. and Ma, K. and Yang, N.N. and Meng, X.L. and Pang, Z.Y. and Xu, D.D.},
title = {Microneedle-mediated delivery of an nir-triggered nanoagent for synergistic anti-biofilm infection therapy},
journal = {European Cells & Materials},
year = {2026},
volume = {55},
doi = {10.22203/ecm.v055a05}
}
EUVIMED